McKesson | MCK - Gross Profit On Sales

Stock Price
754.68
Daily Change
-7.21 -0.95%
Monthly
-10.40%
Yearly
5.00%
Q2 Forecast
745.28

McKesson reported $3.68B in Gross Profit on Sales for its fiscal quarter ending in December of 2025.





Gross Profit On Sales Change Date
Acadia Healthcare USD 790.7M 30.46M Dec/2025
Align Technology USD 736.59M 53M Mar/2026
Cardinal Health USD 2.5B 101M Mar/2026
Centene USD 5.26B 3.12B Mar/2026
Charles River Laboratories USD 279.32M 7.36M Mar/2026
Cigna USD 6.08B 50.37B Mar/2026
Community Health Systems USD 2.76B 70M Dec/2024
Computer Programs Systems USD 35.62M 3.23M Dec/2025
CVS Health USD 15.62B 2.06B Mar/2026
DaVita Healthcare Partners USD 895.46M 128.1M Mar/2026
Dentsply International USD 427M 16M Mar/2026
eHealth USD -42.47M 14.5M Sep/2024
Elevance Health USD 11.68B 889M Dec/2025
Encompass Health USD 1.48B 67.2M Dec/2025
HCA USD 8.18B 161M Dec/2025
Henry Schein USD 1.07B 7M Mar/2026
Humana USD 4.82B 754M Jun/2025
IQVIA Holdings USD 1.07B 52M Mar/2026
J&J USD 17.24B 642M Mar/2026
Laboratory Of America USD 1.01B 20.6M Mar/2026
McKesson USD 3.68B 143M Dec/2025
Molina Healthcare USD 1.49B 292M Mar/2026
Owens Minor USD 272.05M 20.92M Dec/2025
Quest Diagnostics USD 906M 33M Mar/2026
Stryker USD 3.81B 675M Mar/2026
Tenet Healthcare USD 4.52B 2.3B Dec/2025
UnitedHealth USD 18.49B 2.14B Dec/2025
Universal Health Services USD 4.06B 2.05B Dec/2025
Veradigm USD 83.44M 3.95M Sep/2022